Richter Gedeon Vegyeszeti Gyar Nyilvanosan Muko Rt 2022 AR2
The report highlights Gedeon Richter Plc.'s financial and operational performance for the fiscal year 2022, navigating global challenges such as the Russian-Ukrainian conflict and inflationary pressures. Key achievements include a near 30 percent expansion in consolidated sales, driven by the strong performance of its core Women's Healthcare portfolio and royalty income from cariprazine (Vraylar®). Strategically, the company expanded its therapeutic reach by signing a binding agreement with Mithra for the commercialisation of Donesta® and submitting a regulatory application for Ryeqo® in endometriosis. On the ESG front, the company completed its carbon footprint calculation for Hungary, setting a target of a 55 percent reduction by 2030 in line with the EU's 'Fit for 55' program, while continuing to expand solar systems across its sites.
Company: Richter Gedeon Vegyeszeti Gyar Nyilvanosan Muko Rt
Sector: Health Care
Country: Hungary
Year: 2022
Type: AR2
Pages: 339
Richter Gedeon Vegyeszeti Gyar Nyilvanosan Muko Rt
Annual Report
The report highlights Gedeon Richter Plc.'s financial and operational performance for the fiscal year 2022, navigating global challenges such as the Russian-Ukrainian conflict and inflationary pressures. Key achievements include a near 30 percent expansion in consolidated sales, driven by the strong performance of its core Women's Healthcare portfolio and royalty income from cariprazine (Vraylar®). Strategically, the company expanded its therapeutic reach by signing a binding agreement with Mithra for the commercialisation of Donesta® and submitting a regulatory application for Ryeqo® in endometriosis. On the ESG front, the company completed its carbon footprint calculation for Hungary, setting a target of a 55 percent reduction by 2030 in line with the EU's 'Fit for 55' program, while continuing to expand solar systems across its sites.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Workplace Fatalities
Employees